Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease

被引:0
|
作者
Olalla, J
Pulido, F
Rubio, R
Costa, MA
Monsalvo, R
Palenque, E
Costa, JR
Del Palacio, A
机构
[1] Med Interna Serv, Unidad Infecc VIH, Madrid, Spain
[2] Hosp Univ Doce Octubre, Microbiol Lab, Madrid, Spain
关键词
HIV; paradoxical; mycobacterial disease; tuberculosis;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
SETTING: Paradoxical worsening or relapse of opportunistic infections has been described after initiation of highly active anti-retroviral therapy (HAART) in human immunodeficiency virus (HIV) infected patients. DESIGN: Retrospective study of a group of 33 HIV-infected patients with mycobacterial disease analysing the incidence and characteristics of patients with and without paradoxical response after starting HAART and/or mycobacterial treatment. RESULTS: Nine patients in the group had paradoxical response. No significant difference of baseline characteristics was observed in these patients. The decrease in viral load was significantly greater among patients with paradoxical response than in patients without. CONCLUSION: No clinical difference was found in the evolution of HIV-infected patients with mycobacterial disease after the resolution of the episode of paradoxical response.
引用
收藏
页码:71 / 75
页数:5
相关论文
共 50 条
  • [1] Neurosyphilis in a clinical cohort of HIV-1-infected patients
    Chanem, Khalil G.
    Moore, Richard D.
    Rompalo, Anne M.
    Erbelding, Emily J.
    Zenilman, Jonathan M.
    Gebo, Kelly A.
    [J]. AIDS, 2008, 22 (10) : 1145 - 1151
  • [2] Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients
    Yamanaka, H
    Teruya, K
    Tanaka, M
    Kikuchi, Y
    Takahashi, T
    Kimura, S
    Oka, S
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (02) : 167 - 173
  • [3] Lipodystrophy in HIV-1-infected patients
    Domingo, P
    Pérez, A
    Torres, OH
    Montiel, JA
    Vázquez, G
    [J]. LANCET, 1999, 354 (9181): : 868 - 868
  • [4] Safety of Fosamprenavir in a Cohort of HIV-1-infected Patients with Co-morbidities
    Esposito, Vincenzo
    Chiodini, Paolo
    Viglietti, Rosaria
    Parrella, Roberto
    Parrella, Giovanni
    Maddaloni, Adelaide
    Sangiovanni, Vincenzo
    Gargiulo, Miriam
    Abrescia, Nicola
    Chirianni, Antonio
    [J]. IN VIVO, 2011, 25 (05): : 813 - 819
  • [5] Silicone in HIV-1-infected patients: a cause of misdiagnosed granulomatous disease
    Males, Sylvia
    Joly, Veronique
    Adle-Biassette, Homa
    Abgrall, Sophie
    Lariven, Sylvie
    Leboulanger, Nicolas
    Yeni, Patrick
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E277 - E279
  • [6] Cytomegalovirus disease in HIV-1-infected patients treated with protease inhibitors
    Mallolas, J
    Arrizabalaga, J
    Lonca, M
    Gatell, JM
    Adan, A
    MartinezChamorro, E
    Tortajada, C
    RodriguezArrondo, F
    Blanco, A
    Guelar, A
    Soriano, E
    [J]. AIDS, 1997, 11 (14) : 1785 - 1787
  • [7] Neuroimaging in the brain in HIV-1-infected patients
    Thurnher, Majda M.
    Post, M. Judith Donovan
    [J]. NEUROIMAGING CLINICS OF NORTH AMERICA, 2008, 18 (01) : 93 - +
  • [8] Renal dysfunction in HIV-1-infected patients
    Jeffrey B. Kopp
    [J]. Current Infectious Disease Reports, 2002, 4 (5) : 449 - 460
  • [9] Pneumocystis pneumonia in HIV-1-infected patients
    Shibata, Satoshi
    Kikuchi, Toshiaki
    [J]. RESPIRATORY INVESTIGATION, 2019, 57 (03) : 213 - 219
  • [10] Liver transplantation in HIV-1-infected patients
    José M Miró
    [J]. Retrovirology, 7